Evidence map›Paper›PMID 31065832›Full record

ArticleActa neuropathologica2019

BIN1 recovers tauopathy-induced long-term memory deficits in mice and interacts with Tau through Thr

Maxime Sartori, Tiago Mendes, Shruti Desai, Alessia Lasorsa, Adrien Herledan, Nicolas Malmanche, Petra Mäkinen, Mikael Marttinen, Idir Malki, Julien Chapuis and 15 more

Open access · hybridAbstract read
In one paragraph

Article in Acta neuropathologica, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Science advances · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Cell type-specific functions of Alzheimer's disease endocytic risk genes.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Review
  12. Review
  13. Biofluid biomarkers for Alzheimer's disease.Frontiers in aging neuroscience · 2024
    Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 4 institutions in 3 countries.

Maxime SartoriInstitut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), 1 rue Laurent Fries, 67404, Illkirch, France.
Tiago MendesINSERM U1167, RID-AGE: Risk Factors and Molecular Determinants of Aging-Related Diseases, Institut Pasteur de Lille, 1 rue du Pr. Calmette, 59019, Lille, France.
Shruti DesaiINSERM U1167, RID-AGE: Risk Factors and Molecular Determinants of Aging-Related Diseases, Institut Pasteur de Lille, 1 rue du Pr. Calmette, 59019, Lille, France.
Alessia LasorsaUniversity of Lille, DISTALZ Laboratory of Excellence (LabEx), Lille, France.
Adrien HerledanInstitut Pasteur de Lille, Lille, France.
Nicolas MalmancheINSERM U1167, RID-AGE: Risk Factors and Molecular Determinants of Aging-Related Diseases, Institut Pasteur de Lille, 1 rue du Pr. Calmette, 59019, Lille, France.
Petra MäkinenInstitute of Biomedicine, University of Eastern Finland, Kuopio, Finland.
Mikael MarttinenInstitute of Biomedicine, University of Eastern Finland, Kuopio, Finland.
Idir MalkiUniversity of Lille, DISTALZ Laboratory of Excellence (LabEx), Lille, France.
Julien ChapuisINSERM U1167, RID-AGE: Risk Factors and Molecular Determinants of Aging-Related Diseases, Institut Pasteur de Lille, 1 rue du Pr. Calmette, 59019, Lille, France.
Amandine FlaigINSERM U1167, RID-AGE: Risk Factors and Molecular Determinants of Aging-Related Diseases, Institut Pasteur de Lille, 1 rue du Pr. Calmette, 59019, Lille, France.
Anaïs-Camille VreulxINSERM U1167, RID-AGE: Risk Factors and Molecular Determinants of Aging-Related Diseases, Institut Pasteur de Lille, 1 rue du Pr. Calmette, 59019, Lille, France.
Marion CianciaInstitut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), 1 rue Laurent Fries, 67404, Illkirch, France.
Philippe AmouyelINSERM U1167, RID-AGE: Risk Factors and Molecular Determinants of Aging-Related Diseases, Institut Pasteur de Lille, 1 rue du Pr. Calmette, 59019, Lille, France.
Florence LerouxInstitut Pasteur de Lille, Lille, France.
Benoit DéprezInstitut Pasteur de Lille, Lille, France.
François-Xavier CantrelleUniversity of Lille, DISTALZ Laboratory of Excellence (LabEx), Lille, France.
Damien MaréchalInstitut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), 1 rue Laurent Fries, 67404, Illkirch, France.
Laurent PradierSANOFI Neuroscience Therapeutic Area, Chilly-Mazarin, France.
Mikko HiltunenInstitute of Biomedicine, University of Eastern Finland, Kuopio, Finland.
Isabelle LandrieuUniversity of Lille, DISTALZ Laboratory of Excellence (LabEx), Lille, France.
Devrim KilincINSERM U1167, RID-AGE: Risk Factors and Molecular Determinants of Aging-Related Diseases, Institut Pasteur de Lille, 1 rue du Pr. Calmette, 59019, Lille, France.
Yann HeraultInstitut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), 1 rue Laurent Fries, 67404, Illkirch, France. herault@igbmc.fr.
Jocelyn LaporteInstitut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), 1 rue Laurent Fries, 67404, Illkirch, France. jocelyn@igbmc.fr.
Jean-Charles LambertINSERM U1167, RID-AGE: Risk Factors and Molecular Determinants of Aging-Related Diseases, Institut Pasteur de Lille, 1 rue du Pr. Calmette, 59019, Lille, France. jean-charles.lambert@pasteur-lille.fr.ORCID 0000-0003-0829-7817
Inserm · FRCentre National de la Recherche Scientifique · FRUniversity of Eastern Finland · FISanofi (France) · FR

Funding

Academy of Finland 307866Agence Nationale de la Recherche 10-INBS-07694Agence Nationale de la Recherche 15-CE-16-0002Alzheimer's Association BFG-14-318355
6 · The paper itself

Abstract

The bridging integrator 1 gene (BIN1) is a major genetic risk factor for Alzheimer's disease (AD). In this report, we investigated how BIN1-dependent pathophysiological processes might be associated with Tau. We first generated a cohort of control and transgenic mice either overexpressing human MAPT (TgMAPT) or both human MAPT and BIN1 (TgMAPT;TgBIN1), which we followed-up from 3 to 15 months. In TgMAPT;TgBIN1 mice short-term memory deficits appeared earlier than in TgMAPT mice; however-unlike TgMAPT mice-TgMAPT;TgBIN1 mice did not exhibit any long-term or spatial memory deficits for at least 15 months. After killing the cohort at 18 months, immunohistochemistry revealed that BIN1 overexpression prevents both Tau mislocalization and somatic inclusion in the hippocampus, where an increase in BIN1-Tau interaction was also observed. We then sought mechanisms controlling the BIN1-Tau interaction. We developed a high-content screening approach to characterize modulators of the BIN1-Tau interaction in an agnostic way (1,126 compounds targeting multiple pathways), and we identified-among others-an inhibitor of calcineurin, a Ser/Thr phosphatase. We determined that calcineurin dephosphorylates BIN1 on a cyclin-dependent kinase phosphorylation site at T348, promoting the open conformation of the neuronal BIN1 isoform. Phosphorylation of this site increases the availability of the BIN1 SH3 domain for Tau interaction, as demonstrated by nuclear magnetic resonance experiments and in primary neurons. Finally, we observed that although the levels of the neuronal BIN1 isoform were unchanged in AD brains, phospho-BIN1(T348):BIN1 ratio was increased, suggesting a compensatory mechanism. In conclusion, our data support the idea that BIN1 modulates the AD risk through an intricate regulation of its interaction with Tau. Alteration in BIN1 expression or activity may disrupt this regulatory balance with Tau and have direct effects on learning and memory.

Indexed as

Adaptor Proteins, Signal TransducingAlzheimer DiseaseAnimalsBrainMemory DisordersMemory, Long-TermMiceMice, TransgenicNerve Tissue ProteinsNeuronsPhosphorylationSpatial MemoryTauopathiestau ProteinsTumor Suppressor ProteinsAdaptor Proteins, Signal TransducingBin1 protein, mouseNerve Tissue Proteinstau ProteinsTumor Suppressor ProteinsAlzheimer’s diseaseBIN1CalcineurinCdkHigh-content screeningLong-term memoryNeurodegenerationNuclear magnetic resonanceProximity ligation assayTauTauopathy

Identifiers

PMID31065832
PMCPMC6778065
OpenAlexW2951997054

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.